Insulin-like growth factor binding protein-6 inhibits neuroblastoma cell proliferation and tumour development

European Journal of Cancer

Volumn 38, Issue 15, 2002, Pages 2058-2065

  Seurin, D ^a   Lassarre, C ^a   Bienvenu, G ^a   Babajko, S ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Cell proliferation; IGF system; IGFBP 6; Neuroblastoma; Tumour growth

Indexed keywords

RECOMBINANT PROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 6;

ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CELL ASSAY; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; IMPLANTATION; IN VIVO STUDY; MINIPUMP; MITOGENESIS; NEUROBLASTOMA CELL; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TIME;

ANIMALS; CELL DIVISION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0036790887     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00240-X     Document Type: Article

References (50)

1. El-Badry O.M., Romanus J.A., Helman L.J., Cooper M.J., Rechler M.M., Israel M.A. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest. 84:1989;829-839.
2. Kurihara S., Hakuno F., Takahashi S. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y. the roles of MAP kinase pathway and PI 3-kinase pathway Endocr J. 47:2000;739-751.
3. Suarez A., Hartmann O., Vassal G.et al. Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987. Med Pediatr Oncol. 19:1991;473-477.
4. Sullivan K.A., Castle V.P., Hanash S.M., Feldman E.L. Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol. 147:1995;1790-1798.
5. Toretsky J.A., Helman L.J. Involvement of IGF-II in human cancer. J Endocrinol. 149:1996;367-372.
6. De Meyts P., Wallach B., Christoffersen C.T.et al. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction. Horm Res. 42:1994;152-169.
7. Liu X., Turbyville T., Fritz A., Whitesell L. Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res. 58:1998;5432-5438.
8. Valentinis B., Baserga R. IGF-I receptor signalling in transformation and differentiation. Mol Pathol. 54:2001;133-137.
9. Peruzzi F., Prisco M., Morrione A., Valentinis B., Baserga R. Anti-apoptotic signaling of the insulin-like growth factor-I receptor through mitochondrial translocation of c-Raf and Nedd4. J Biol Chem. 276:2001;25990-25996.
10. Zumkeller W., Schwab M. Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis. potential diagnostic and therapeutic perspectives Horm Metab Res. 31:1999;138-141.
11. Chambery D., Mohseni-Zadeh S., de Galle B., Babajko S. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Cancer Res. 59:1999;2898-2902.
12. Misawa A., Hosoi H., Arimoto A.et al. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res. 60:2000;64-69.
13. Lau M.M., Stewart C.E., Liu Z., Bhatt H., Rotwein P., Stewart C. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 24:1994;2953-2963.
14. Shimasaki S., Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res. 3:1991;243-266.
15. Cohick W.S., Clemmons D.R. The insulin-like growth factors. Annu. Rev. Physiol. 55:1993;131-153.
16. Grimberg A., Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 183:2000;1-9.
17. Liu B., Lee H.Y., Weinzimer S.A.et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem. 275:2000;33607-33613.
18. Mannhardt B., Weinzimer S.A., Wagner M.et al. Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitoryinsulin-like growth factor binding protein 3. Mol Cell Biol. 20:2000;6483-6495.
19. van Kleffens M., Groffen C.A., Dits N.F.et al. Generation of antisera to mouse insulin-like growth factor binding proteins (IGFBP)-1 to -6: comparison of IGFBP protein and messenger ribonucleic acid localization in the mouse embryo. Endocrinology. 140:1999;5944-5952.
20. Roghani M., Segovia B., Whitechurch O., Binoux M. Purification from human cerebrospinal fluid of insulin-like growth factor binding proteins (IGFBPs). Isolation of IGFBP-2, an altered form of IGFBP-3 and a new IGFBP species. Growth Regul. 3:1991;125-130.
21. Gabbitas B., Canalis E. Retinoic acid stimulates the transcription of insulin-like growth factor binding protein-6 in skeletal cells. J Cell Physiol. 169:1996;15-22.
22. Gabbitas B., Canalis E. Cortisol enhances the transcription of insulin-like growth factor-binding protein-6 in cultured osteoblasts. Endocrinology. 137:1996;1687-1692.
23. Babajko S., Leneuve P., Loret C., Binoux M. IGF-binding protein-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells. its production is both IGF- and cell density-dependent J Endocrinol. 152:1997;221-227.
24. Drivdahl R.H., Loop S.M., Andress D.L., Ostenson R.C. IGF-binding proteins in human prostate tumor cells. expression and regulation by 1,25-dihydroxyvitamin D3 Prostate. 26:1995;72-79.
25. Chambery D., De Galle B., Ehrenborg E., Babajko S. Multi-hormonal regulation of IGFBP-6 expression in human neuroblastoma cells. Growth Horm IGF Res. 10:2000;349-359.
26. Babajko S., Binoux M. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells. Eur J Endocrinol. 134:1996;474-480.
27. Bernardini S., Cianfarani S., Spagnoli A.et al. Expression and down-regulation by retinoic acid of IGF binding protein-2 and -4 in medium from human neuroblastoma cells. J Neuroendocrinol. 6:1994;409-413.
28. Grellier P., De Galle B., Babajko S. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res. 58:1998;1670-1676.
29. Binoux M., Seurin D., Lassarre C., Gourmelen M. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF-BPs) produced by rat liver in culture. Estimation of serum IGFBP levels. J Clin Endocrinol Metab. 59:1984;453-462.
30. Ferrandis E., Da Silva J., Riou G., Benard J. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res. 54:1994;2256-2261.
31. Biedler J.L., Helson L., Spengler B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:1973;2643-2652.
32. Babajko S., Hardouin S., Segovia B., Groyer A., Binoux M. Expression of insulin-like growth factor binding protein-1 and -2 genes through the perinatal period in the rat. Endocrinology. 132:1993;2586-2592.
33. El-Badry O.M., Helman L.J., Chatten J., Steinberg S.M., Evans A.E., Israel M.A. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest. 87:1991;648-657.
34. Singleton J., Randolph A., Feldman E.L. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res. 56:1966;4522-4529.
35. Menouny M., Binoux M., Babajko S. Role of insulin-like growth factor binding protein-2 and its limited proteolysis in neuroblastoma cell proliferation. modulation by transforming growth factor-beta and retinoic acid Endocrinology. 138:1997;683-690.
36. Renehan A.G., Jones J., Potten C.S., Shalet S.M., O'Dwyer S.T. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br J Cancer. 83:2000;1344-1350.
37. Elminger M.W., Bell M., Schuett B.S., Langkamp M., Kutoh E., Ranke M.B. Transactivation of the IGFBP-2 promoter in human tumor cell lines. Mol Cell Endocrinol. 175:2001;211-218.
38. Menouny M., Binoux M., Babajko S. IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. Int J Cancer. 77:1998;874-879.
39. Hoeflich A., Fettscher O., Lahm H. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res. 60:2000;834-838.
40. Kato M., Ishizaki A., Hellman U.et al. Human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-beta and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. J Biol Chem. 270:1995;12373-12379.
41. Schmid C., Schlapfer I., Keller A., Waldvogel M., Froesch E.R., Zapf J. Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts. further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth Biochem. Biophys. Res. Commun. 212:1995;242-248.
42. Sueoka N., Lee H.Y., Wiehle S.et al. Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene. 19:2000;4432-4436.
43. Sueoka N., Lee H.Y., Walsh G.L.et al. Insulin-like growth factor binding protein-6 inhibits the growth of human bronchialepithelial cells and increases in abundance with all-trans-retinoic acid treatment. Am. J. Respir. Cell Mol. Biol. 23:2000;297-303.
44. Bach L.A., Hsieh S., Sakano K., Fujiwara H., Perdue J.F., Rechler M.M. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. J Biol Chem. 268:1993;9246-9254.
45. Leng S.L., Leeding K.S., Whitehead R.H., Bach L.A. Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basalproliferation and adhesion of LIM 1215 colon cancer cells. Mol Cell Endocrinol. 174:2001;121-127.
46. Bach L.A., Hsieh S., Brown A.L., Rechler M.M. Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Endocrinology. 135:1994;2168-2176.
47. Bach L.A. Insulin-like growth factor binding protein-6. the "forgotten" binding protein? Horm Metab Res. 31:1999;226-234.
48. Marinaro J.A., Casley D.J., Bach L.A. O-Glycosylation delays the clearance of human IGF-binding protein-6 from the circulation. Eur J Endocrinol. 142:2000;512-516.
49. Shalamanova L., Kubler B., Scharf J.G., Braulke T. MDCK cells secrete neutral proteases cleaving insulin-like growth factor-binding protein-2 to -6. Am. J. Physiol. Endocrinol Metab. 281:2001;E1221-E1229.
50. Drivdahl R.H., Sprenger C., Trimm K., Plymate S.R. Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and -6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid. Endocrinology. 142:2001;1990-1998.